Novoprotein Scientific Inc. (SHA:688137)

Market Cap	5.06B +65.1%
Revenue (ttm)	152.84M +9.2%
Net Income	-82.76M
EPS	-1.18
Shares Out	69.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,709,730
Open	69.50
Previous Close	68.77
Day's Range	69.00 - 73.78
52-Week Range	33.20 - 90.90
Beta	1.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 636
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688137

Financial Performance

In 2025, Novoprotein Scientific's revenue was 146.44 million, an increase of 14.80% compared to the previous year's 127.56 million. Losses were -77.78 million, 42.9% more than in 2024.

Data Sources: S&P Global Market Intelligence and Alpha Vantage

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Alpha Vantage.

Last checked:

Sep 2, 2026

Data Sources Report a data error